Association between CYP2D6*10 and ADRB1 Polymorphisms on Metoprolol Efficacy in Hypertensive Patients
Objectives: To investigate the impact of CYP2D610 and ADRB1 (1165G>C) polymorphisms on metoprolol treatment outcomes in hypertensive patients. Methodology: A total of three hundred hypertensive patients, treated in the First Affiliated Hospital of Qiqihar Medical University between May 2023 to May 2024, who received tr...